Merck's Potential Blockbuster Cholesterol Pill Succeeds in Late-Stage Studies
Favicon 
www.newsmax.com

Merck's Potential Blockbuster Cholesterol Pill Succeeds in Late-Stage Studies

Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers beyond its cancer drugs and vaccines.